Willner & Heller’s Pfizer PFE Stock Holding History

Willner & Heller’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-7,911	Closed	-$200K	–	155
2025 Q1	$200K	Sell	7,911 -2,490	-24%	-$65.2K	0.19%	145
2024 Q4	$276K	Buy	10,401 +334	+3%	+$9.06K	0.24%	126
2024 Q3	$291K	Sell	10,067 -4,090	-29%	-$119K	0.26%	120
2024 Q2	$396K	Sell	14,157 -9,070	-39%	-$250K	0.38%	90
2024 Q1	$645K	Buy	23,227 +3,405	+17%	+$94.5K	0.64%	49
2023 Q4	$571K	Buy	+19,822	New	+$599K	0.64%	50
2022 Q4	$683K	Buy	13,329 +219	+2%	+$10.5K	0.97%	33
2022 Q3	$574K	Buy	13,110 +1,064	+9%	+$51.7K	0.93%	34
2022 Q2	$632K	Buy	12,046 +88	+0.7%	+$4.48K	0.98%	32
2022 Q1	$706K	Sell	11,958 -755	-6%	-$39.2K	0.87%	37
2021 Q4	$547K	Buy	+12,713	New	+$630K	0.73%	46

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Willner & Heller's PFE Position: Q2 2025 in Review

Willner & Heller sold out of Pfizer (PFE) in Q2 2025, closing a stake of 7,911 shares — an estimated $200K sold.

Willner & Heller first reported a position in PFE in Q4 2021 and held it in 11 quarters. The position peaked at $706K in Q1 2022. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

Willner & Heller reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
Willner & Heller sold 7,911 Pfizer shares in Q2 2025, an estimated $200K.
Willner & Heller first reported a position in Pfizer in Q4 2021 and held it in 11 quarters.
Willner & Heller's Pfizer position peaked at $706K in Q1 2022.
2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Willner & Heller's 13F filing for Q2 2025, filed 22 Jul 2025.